Compound Evidence File
#EC-2026-0256
Semaglutide(GLP-1 agonist)
Filed under Peptides. The bureau holds 394 laboratory returns for this compound from 77 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
77 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 7 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 9.9 | 10.0 | 10 Mar 2026 | 5 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 10.0 | 10.0 | 10.0 | 7 Jan 2026 | 6 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 10.0 | 10.0 | 10.0 | 25 Jan 2026 | 7 Mar 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 10.0 | 10.0 | 10.0 | 25 Mar 2026 | 16 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 10.0 | 10.0 | 9 Mar 2026 | 10 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 9.9 | 10.0 | 9 Dec 2025 | 6 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 9.9 | 10.0 | 18 Nov 2025 | 14 May 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 9.9 | 10.0 | 8 Jan 2026 | 14 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 10.0 | 9.9 | 10.0 | 10 Dec 2025 | 26 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 10.0 | 9.9 | 10.0 | 4 Dec 2025 | 26 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 10.0 | 10.0 | 10.0 | 4 Mar 2026 | 9 May 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 10.0 | 10.0 | 10.0 | 15 Apr 2026 | 3 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 10.0 | 10.0 | 10.0 | 17 Dec 2025 | 14 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 10.0 | 10.0 | 10.0 | 12 Apr 2026 | 14 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 9.9 | 9.9 | 10.0 | 26 Jan 2026 | 24 May 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 1 Dec 2025 | 7 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 9.9 | 9.9 | 10.0 | 21 Feb 2026 | 15 Jul 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 9.9 | 9.9 | 10.0 | 4 Feb 2026 | 6 Aug 2026 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | A | 3 | 9.9 | 9.8 | 10.0 | 5 Dec 2025 | 18 May 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 9.9 | 9.9 | 10.0 | 1 Jan 2026 | 20 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 9.9 | 9.9 | 10.0 | 13 Dec 2025 | 19 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 9.9 | 9.9 | 10.0 | 26 Mar 2026 | 23 Jun 2026 |
| InjectifyCASE #VI-2026-0387 | A | 4 | 9.5 | 8.4 | 10.0 | 16 May 2025 | 22 Jul 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 5 | 9.2 | 8.6 | 9.7 | 24 May 2026 | 24 May 2026 |
| NextechLabsCASE #VI-2026-0285 | A | 2 | 9.1 | 9.0 | 9.3 | 14 Jan 2025 | 23 Jan 2025 |
| Peptide TechnologiesCASE #VI-2026-0694 | A | 4 | 8.8 | 7.2 | 10.0 | 27 Feb 2025 | 20 Mar 2025 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | A | 2 | 8.8 | 8.0 | 9.7 | 30 Dec 2025 | 30 Dec 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 6 | 8.5 | 7.4 | 8.9 | 21 May 2026 | 21 May 2026 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | A | 5 | 8.5 | 7.1 | 10.0 | 29 Jun 2025 | 9 Jan 2026 |
| Pure RawzCASE #VI-2026-0767 | A | 4 | 8.4 | 7.9 | 9.0 | 6 May 2025 | 21 May 2025 |
| Peptide CraftersCASE #VI-2026-0994 | A | 10 | 8.3 | 6.4 | 9.0 | 17 Dec 2024 | 20 Mar 2025 |
| Astro PeptidesCASE #VI-2026-0424 | A | 7 | 8.3 | 6.7 | 9.7 | 22 Apr 2025 | 5 May 2025 |
| Verified PeptidesCASE #VI-2026-0407 | A | 4 | 8.3 | 7.9 | 8.9 | 13 Feb 2025 | 19 Feb 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 8.3 | 7.6 | 8.9 | 21 May 2026 | 21 May 2026 |
| Skye PeptidesCASE #VI-2026-0451 | A | 9 | 8.2 | 7.2 | 8.6 | 17 Dec 2024 | 20 Mar 2025 |
| DeuschemCASE #VI-2026-0004 | A | 4 | 8.2 | 7.7 | 9.0 | 14 Jun 2025 | 5 Aug 2025 |
| UtherCASE #VI-2026-0902 | A | 3 | 8.0 | 7.3 | 8.8 | 9 Oct 2025 | 29 Dec 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 6 | 7.8 | 6.1 | 9.8 | 24 May 2026 | 24 May 2026 |
| Amino AsylumCASE #VI-2026-0828 | A | 2 | 7.8 | 7.6 | 8.0 | 14 Feb 2025 | 19 Feb 2025 |
| Nuscience PeptidesCASE #VI-2026-0554 | B | 14 | 7.8 | 5.6 | 10.0 | 14 Apr 2025 | 10 Sep 2025 |
| Amino AmigosCASE #VI-2026-0061 | A | 7 | 7.7 | 6.5 | 9.8 | 14 Jan 2025 | 20 Mar 2025 |
| Tianjin Ruiwang New Material Technology CoCASE #VI-2026-0192 | A | 4 | 7.7 | 6.8 | 8.4 | 21 Oct 2025 | 13 Dec 2025 |
| Atomik LabzCASE #VI-2026-0327 | A | 4 | 7.7 | 6.5 | 8.2 | 6 May 2025 | 6 May 2025 |
| Bfflist AMOCASE #VI-2026-0678 | B | 3 | 7.7 | 5.3 | 9.0 | 29 Jun 2025 | 25 Nov 2025 |
| Planet PeptideCASE #VI-2026-0092 | A | 8 | 7.5 | 6.9 | 9.0 | 17 Dec 2024 | 6 May 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 2 | 7.5 | 7.3 | 7.8 | 21 May 2026 | 21 May 2026 |
| Peptide SciencesCASE #VI-2026-0867 | B | 15 | 7.5 | 5.0 | 9.8 | 17 Dec 2024 | 24 May 2026 |
| Forever Young PharmacyCASE #VI-2026-0654 | A | 5 | 7.4 | 6.3 | 8.5 | 17 Dec 2024 | 19 Feb 2025 |
| Liberty PeptidesCASE #VI-2026-0416 | A | 5 | 7.4 | 6.2 | 8.0 | 28 Mar 2025 | 24 Oct 2025 |
| Simple PeptideCASE #VI-2026-0782 | A | 4 | 7.4 | 6.3 | 9.5 | 25 Apr 2025 | 6 May 2025 |
| Accelerate LabsCASE #VI-2026-0686 | A | 3 | 7.3 | 7.1 | 7.6 | 16 May 2025 | 22 Jul 2025 |
| SRY LabsCASE #VI-2026-0657 | B | 4 | 7.3 | 5.5 | 9.6 | 29 Jun 2025 | 15 Jan 2026 |
| Peptide-SCASE #VI-2026-0111 | B | 5 | 7.2 | 5.6 | 9.0 | 16 Jul 2025 | 15 Jan 2026 |
| HK PeptidesCASE #VI-2026-0140 | A | 8 | 7.1 | 6.2 | 8.0 | 9 Jul 2025 | 26 Jan 2026 |
| Royal PeptidesCASE #VI-2026-0264 | B | 7 | 7.0 | 5.8 | 8.9 | 16 Mar 2025 | 3 Aug 2025 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | C | 4 | 7.0 | 4.3 | 8.0 | 4 Sep 2025 | 17 Dec 2025 |
| Polaris PeptidesCASE #VI-2026-0839 | C | 16 | 6.9 | 4.7 | 8.7 | 17 Dec 2024 | 12 Aug 2025 |
| Alpha-GenCASE #VI-2026-0905 | B | 5 | 6.8 | 5.4 | 7.6 | 24 Apr 2025 | 21 May 2025 |
| Precision Peptide CoCASE #VI-2026-0559 | B | 4 | 6.8 | 5.0 | 9.0 | 7 May 2025 | 16 May 2025 |
| Peptide GurusCASE #VI-2026-0854 | B | 6 | 6.5 | 5.9 | 7.3 | 16 Mar 2025 | 25 Mar 2025 |
| Suaway Lab ResearchCASE #VI-2026-0488 | B | 5 | 6.5 | 5.8 | 7.4 | 28 Mar 2025 | 22 Jul 2025 |
| Eternal PeptidesCASE #VI-2026-0842 | B | 4 | 6.4 | 5.7 | 7.5 | 7 May 2025 | 21 May 2025 |
| Paramount PeptidesCASE #VI-2026-0550 | C | 9 | 6.3 | 4.6 | 8.9 | 14 Jan 2025 | 6 May 2025 |
| Elite Research USACASE #VI-2026-0267 | C | 9 | 6.3 | 4.5 | 8.0 | 25 Apr 2025 | 5 Aug 2025 |
| NexaphCASE #VI-2026-0944 | C | 14 | 6.2 | 4.5 | 7.5 | 11 Jun 2025 | 22 Jul 2025 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | C | 6 | 6.2 | 4.5 | 8.0 | 14 Jun 2025 | 5 Aug 2025 |
| Platinum CryoCASE #VI-2026-0406 | B | 6 | 6.1 | 5.2 | 8.0 | 22 Apr 2025 | 7 May 2025 |
| ZLZ PeptideCASE #VI-2026-0524 | E | 8 | 5.8 | 2.5 | 7.9 | 11 Jun 2025 | 19 May 2026 |
| Amplified AminoCASE #VI-2026-0748 | C | 4 | 5.2 | 4.8 | 5.5 | 13 Feb 2025 | 19 Feb 2025 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | C | 2 | 5.1 | 5.1 | 5.2 | 7 May 2025 | 7 May 2025 |
| OupeptideCASE #VI-2026-0435 | E | 6 | 5.1 | 0.0 | 7.2 | 5 Aug 2025 | 29 Jan 2026 |
| TydesCASE #VI-2026-0493 | D | 9 | 4.9 | 4.4 | 5.4 | 17 Dec 2024 | 30 Apr 2025 |
| Loti LabsCASE #VI-2026-0171 | D | 4 | 4.9 | 4.6 | 5.0 | 16 Mar 2025 | 25 Mar 2025 |
| Peptides For SaleCASE #VI-2026-0614 | D | 4 | 4.6 | 3.6 | 6.0 | 27 Feb 2025 | 20 Mar 2025 |
| Coastal PeptidesCASE #VI-2026-0958 | E | 6 | 0.8 | 0.0 | 5.0 | 28 Feb 2025 | 28 Mar 2025 |
Open any subject to view the batch-level evidence for Semaglutide(GLP-1 agonist) alone.